🇺🇸 FDA

Intelligence · Patent portfolio

Xenon Pharmaceuticals Patents

Full USPTO pharma patent portfolio for Xenon Pharmaceuticals — grant dates, expiration, and drug cross-links.

Patents
106
Expiring ≤24m
5

Quick answer

Xenon Pharmaceuticals has 106 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 3

  1. US 8742109

    Synthetic methods for spiro-oxindole compounds

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8715968

    Methods and reagents for modulating cholesterol levels

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8541457

    Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8507435

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8501746

    Organic compounds

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8466188

    Use of spiro-oxindole compounds as therapeutic agents

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8450358

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8445696

    Synthetic methods for spiro-oxindole compounds

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8415370

    Spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8410054

    Methods for treating pain by inhibition of the SCN9A channel

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8383628

    Pyridyl derivatives and their use as therapeutic agents

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8263606

    Spiro-oxindole compounds and their use as therapeutic agents

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8252578

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8236835

    Heterocyclic inhibitors of stearoyl-CoA desaturase

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8153636

    Pyridyl derivatives and their use as therapeutic agents

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8148378

    Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8106087

    Spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8101647

    Spiro-oxindole compounds and their use as therapeutic agents

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8080651

    Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8067219

    Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8063084

    Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8049016

    Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8030488

    Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8026360

    Substituted pyridazines as stearoyl-CoA desaturase inhibitors

    Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7964591

    Pyridazine derivatives and their use as therapeutic agents

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7951805

    Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7935721

    Spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7919496

    Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7919484

    Combination therapy

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7893206

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7829712

    Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7816075

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7799798

    Spiroheterocyclic compounds and their uses as therapeutic agents

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7785886

    Methods and reagents for modulating cholesterol levels

    Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7777036

    Heterocyclic derivatives and their use as therapeutic agents

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7767677

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7763618

    Pyridyl derivatives and their use as therapeutic agents

    Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7759348

    Pyridazine derivatives and their use as therapeutic agents

    Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7754711

    Pyridazine derivatives and their use as therapeutic agents

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7700641

    Spiro-oxindole compounds and their uses as therapeutic agents

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7696151

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7659082

    Methods for identifying analgesic agents

    Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7605161

    Pyridyl derivatives and their use as therapeutic agents

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7592343

    Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors

    Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7547698

    Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7514436

    Pyridazine derivatives and their use as therapeutic agents

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7511018

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Xenon Pharmaceuticals have?

106 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Xenon Pharmaceuticals patents expire?

5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.